Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Minguet

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
International Journal of Cancer|November 6, 2015
Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectivesJoan Minguet, Katherine H Smith, Peter Bramlage
Asian Pacific Journal of Cancer Prevention : APJCP|September 28, 2017
Cancer Incidence in Saudi Arabia: 2012 Data from the Saudi Cancer RegistryShouki Bazarbashi, Haya Al Eid, Joan Minguet
Expert Opinion on Biological Therapy|October 15, 2014
U300, a novel long-acting insulin formulationGemma Sutton, Joan Minguet, Carmen Ferrero, et al.
European Journal of Preventive Cardiology|November 1, 2016
The polypill: An effective approach to increasing adherence and reducing cardiovascular event riskPeter Bramlage, Helen Sims, Joan Minguet, et al.
Expert Review of Hematology|November 5, 2016
Betrixaban - the next direct factor Xa inhibitor?Martin Thoenes, Joan Minguet, Karin Bramlage, et al.
Expert Review of Clinical Pharmacology|November 8, 2016
The factor xa inhibitor edoxaban for the prevention of stroke and systemic embolism in patients with atrial fibrillationJoan Minguet, Helen M Sims, Katherine H Smith, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2015
Targeted therapies for treatment of renal cell carcinoma: recent advances and future perspectivesJoan Minguet, Katherine H Smith, Carsten P Bramlage, et al.
Expert Opinion on Pharmacotherapy|January 20, 2015
LCZ696 : a new paradigm for the treatment of heart failure?Joan Minguet, Gemma Sutton, Carmen Ferrero, et al.
BMC Research Notes|October 26, 2016
Characterization and history of arterial hypertension leading to inpatient treatmentCarsten P Bramlage, Mina Nasiri-Sarvi, Joan Minguet, et al.
European Journal of Heart Failure|December 5, 2015
Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal diseasePeter Bramlage, Stephanie L Swift, Martin Thoenes, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|November 6, 2015
Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectivesJoan Minguet, Katherine H Smith, Peter Bramlage
Asian Pacific Journal of Cancer Prevention : APJCP|September 28, 2017
Cancer Incidence in Saudi Arabia: 2012 Data from the Saudi Cancer RegistryShouki Bazarbashi, Haya Al Eid, Joan Minguet
Expert Opinion on Biological Therapy|October 15, 2014
U300, a novel long-acting insulin formulationGemma Sutton, Joan Minguet, Carmen Ferrero, et al.
European Journal of Preventive Cardiology|November 1, 2016
The polypill: An effective approach to increasing adherence and reducing cardiovascular event riskPeter Bramlage, Helen Sims, Joan Minguet, et al.
Expert Review of Hematology|November 5, 2016
Betrixaban - the next direct factor Xa inhibitor?Martin Thoenes, Joan Minguet, Karin Bramlage, et al.
Expert Review of Clinical Pharmacology|November 8, 2016
The factor xa inhibitor edoxaban for the prevention of stroke and systemic embolism in patients with atrial fibrillationJoan Minguet, Helen M Sims, Katherine H Smith, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2015
Targeted therapies for treatment of renal cell carcinoma: recent advances and future perspectivesJoan Minguet, Katherine H Smith, Carsten P Bramlage, et al.
Expert Opinion on Pharmacotherapy|January 20, 2015
LCZ696 : a new paradigm for the treatment of heart failure?Joan Minguet, Gemma Sutton, Carmen Ferrero, et al.
BMC Research Notes|October 26, 2016
Characterization and history of arterial hypertension leading to inpatient treatmentCarsten P Bramlage, Mina Nasiri-Sarvi, Joan Minguet, et al.
European Journal of Heart Failure|December 5, 2015
Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal diseasePeter Bramlage, Stephanie L Swift, Martin Thoenes, et al.
Pageof 2